Drug Registration and Acceptance

Drug Name

Exact

Active Ingredient

Acceptance No.

Manufacturers

Acceptance Date

Status Date

Classification

Review Status

Drug Type

Submission

Evaluation Conclusion

ATC Category

Special Approval Varieties

Task Type

Major Special Varieties

Sequence No.

Stock Code

Visualized Analysis Export Evaluation Conclusion Evaluation Progress

Acceptance No.	Drug Name	Active Ingredient	Dosage Form	Classification	Submission	Acceptance Date	Manufacturers	Review Status	Status Date	View
JXSS2400093	伊匹木单抗注射液	ipilimumab	Injection	Biological Products(3.1)	Import Drug Application	2024-10-13	Bristol-Myers Squibb Pharma Eeig;Bristol-Myers Squibb Holdings Pharma Ltd Liability Company;BRISTOL-MYERS Squibb (CHINA) Co Ltd			view
JXSL1700023	伊匹木单抗注射液	ipilimumab	Injection	Biological Products	Import Drug Application	2017-05-22	Bristol-Myers Squibb Company	Certificate Issued	2017-10-12	view
JXSB2101005	伊匹木单抗注射液	ipilimumab	Injection	Biological Products(2.2)	Supplementary Application	2021-04-28	Bristol-Myers Squibb Holdings Pharma Ltd Liability Company;Bristol-Myers Squibb Company			view
JXSL1900096	伊匹木单抗注射液	ipilimumab	Injection	Biological Products	Import Drug Application	2019-09-28	Bristol-Myers Squibb Company	In Review	2019-09-27	view
JXSS2400038	伊匹木单抗注射液	ipilimumab	Injection	Biological Products(2.2)	Import Drug Application	2024-04-18	Bristol-Myers Squibb Pharma Eeig;Bristol-Myers Squibb Holdings Pharma Ltd Liability Company;BRISTOL-MYERS Squibb (CHINA) Co Ltd			view
JXSL1700068	伊匹木单抗注射液	ipilimumab	Injection	Biological Products	Import Drug Application	2017-10-26	Bristol-Myers Squibb Company	Certificate Issued	2018-04-10	view
JYSB2300080	伊匹木单抗注射液	ipilimumab	Injection	Biological Products	Supplementary Application	2023-04-29	Bristol-Myers Squibb Pharma Eeig;Bristol-Myers Squibb Holdings Pharma Ltd Liability Company			view
JXSS2400055	伊匹木单抗注射液	ipilimumab	Injection	Biological Products(2.2)	Import Drug Application	2024-07-13	Bristol-Myers Squibb Pharma Eeig;Bristol-Myers Squibb Holdings Pharma Ltd Liability Company;BRISTOL-MYERS Squibb (CHINA) Co Ltd			view
JXSB2000016	伊匹木单抗注射液	ipilimumab	Injection	Biological Products	Supplementary Application	2020-09-19	Bristol-Myers Squibb Holdings Pharma Ltd Liability Company;Bristol-Myers Squibb Company	In Review	2020-09-18	view
JXSL1700003	伊匹木单抗注射液	ipilimumab	Injection	Biological Products	Import Drug Application	2017-02-03	Bristol-Myers Squibb Company	Certificate Issued	2017-07-04	view
JXSB2101090	伊匹木单抗注射液	ipilimumab	Injection	Biological Products	Supplementary Application	2021-11-12	Bristol-Myers Squibb Holdings Pharma Ltd Liability Company;Bristol-Myers Squibb Company			view
JXSL1900084	伊匹木单抗注射液	ipilimumab	Injection	Biological Products	Import Drug Application	2019-09-16	Bristol-Myers Squibb Company	In Review	2019-09-13	view
JXSS2400040	伊匹木单抗注射液	ipilimumab	Injection	Biological Products(2.2)	Import Drug Application	2024-04-18	Bristol-Myers Squibb Pharma Eeig;Bristol-Myers Squibb Holdings Pharma Ltd Liability Company;BRISTOL-MYERS Squibb (CHINA) Co Ltd			view
JXSL2000103	伊匹木单抗注射液	ipilimumab	Injection	Biological Products	Import Drug Application	2020-07-04	Bristol-Myers Squibb Company	In Review	2020-07-03	view
JXSL1700035	伊匹木单抗注射液	ipilimumab	Injection	Biological Products	Import Drug Application	2017-07-10	Bristol-Myers Squibb Company	Certificate Issued	2017-12-20	view
JYSB2101118	伊匹木单抗注射液	ipilimumab	Injection	Biological Products	Supplementary Application	2021-08-31	Bristol-Myers Squibb Pharma Eeig;Bristol-Myers Squibb Holdings Pharma Ltd Liability Company			view
CXSL2101073	IBI310	ipilimumab	Injection	Biological Products(2.2)	New Drug Application	2021-05-14	Innovent Biologics (Suzhou) Co Ltd			view
CXSL2300420	IBI310	ipilimumab	Injection	Biological Products(2.2)	New Drug Application	2023-06-19	Innovent Biologics (Suzhou) Co Ltd			view
JYSB2000281	伊匹木单抗注射液	ipilimumab	Injection	Biological Products	Supplementary Application	2020-06-30	Bristol-Myers Squibb Holdings Pharma Ltd Liability Company;Bristol-Myers Squibb Company	In Review	2020-06-29	view
CXSS2500032	伊匹木单抗注射液	ipilimumab	Injection	Biological Products(2.2)	New Drug Application	2025-02-22	Xinda Biopharmaceutical Technology (Hangzhou) Co Ltd;Innovent Biologics (Suzhou) Co Ltd			view